DL-Homocysteinethiolactone hydrochloride

We are DL-Homocysteinethiolactone hydrochloride CAS:6038-19-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 6038-19-3
Product Name: DL-Homocysteinethiolactone hydrochloride
Other Name:
DL-Homocysteinethiolactone hydrochloride
3-Aminodihydro-2(3H)-thiophenone hydrochloride
Homocysteine thiolactone hydrochloride
3-Aminodihydrothiophen-2(3H)-one hydrochloride
1,4-thiolactone hydrochloride
D,L-homocysteine thiolactone hydrochloride
 
Density: 0.862 g/cm3
Boiling Point: 253.8ºC at 760 mmHg
Melting Point: 202 °C (dec.)(lit.)
Molecular Formula: C4H8ClNOS
Molecular Weight: 153.630
Flash Point: 107.3ºC
Exact Mass: 153.001511
PSA: 68.39000
LogP: 1.47950
Water Solubility: 740.5 g/L (20 C)
 
Specification
Appearance: White Crystalline Powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
Acidity: ≤0.5%
 
Application
Intermediates of Erdosteine CAS: 84611-23-4.
Be used as pharmaceutical intermediate, mainly used in the synthesis of Erdosteine.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

DL-Homocysteinethiolactone hydrochloride


Related News: Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.4-Chloro-2-fluorotoluene At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.2-(4-aminomethylphenyl)benzamide The fine and functional chemicals sector provides new growth drivers.4- (2-metoxietil) fenol CAS:56718-71-9 The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Related Products
Product Name
CAS:16881-77-9 Dow Corning Z-6701 View Details
Methyl 2-bromo-3-methylbutanoate View Details
Boron chloride – N,N-dimethylmethanamine View Details
D-Glutamic acid di-tert-butyl ester hydrochloride manufacturer Fmoc-HoArg-OH manufacturer Methyl 2-methyl-3-nitrobenzoate manufacturer Tetrafluoroterephthalic acid Cas:652-36-8 manufacturer Calcium 3-hydroxybutyrate manufacturer